Eicosapentaenoic Acid (EPA) Decreases the All-Cause Mortality in Hemodialysis Patients-Reference-Cited by-同舟云学术

Eicosapentaenoic Acid (EPA) Decreases the All-Cause Mortality in Hemodialysis Patients

Published:2015 Issue:24 Volume:54 Page:3133-3137
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Inoue Tomoko¹,Okano Kazuhiro¹²,Tsuruta Yuki³,Tsuruta Yukio³,Tsuchiya Ken¹²,Akiba Takashi²,Nitta Kosaku¹

Affiliation:

1. Department of Medicine, Kidney Center, Tokyo Women's Medical University, Japan

2. Department of Blood Purification, Kidney Center, Tokyo Women's Medical University, Japan

3. Tsuruta Clinic, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/54/24/54_54.4931/_pdf

Reference25 articles.

1. 1. US Renal Data System. USRDS 1998 Annual Data Report. Am J Kidney Dis 32: S69-S80, 1998.

2. 2. Kasiske BL. Hyperlipidemia in patients with chronic kidney disease. Am J Kidney Dis 32: S142-S156, 1998.

3. 3. Shoji T, Nishizawa Y, Kawagishi T, et al. Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. J Am Soc Nephrol 9: 1277-1284, 1998.

4. 4. Ikizler TA, Morrow JD, Roberts LJ, et al. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol 58: 190-197, 2002.

5. 5. Ando M, Sanaka T, Nihei H. Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vitro peroxidation of LDL in dialysis patients. J Am Soc Nephrol 10: 2177-2184, 1999.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multidimensional benefits of eicosapentaenoic acid: from heart health to inflammatory control;The Egyptian Journal of Internal Medicine;2023-12-12

2. Eicosanoids and Related Metabolites Associated with ESKD in a Community-Based Cohort;Kidney360;2023-12-04

3. Zinc Deficiency, Plasma Fatty Acid Profile and Desaturase Activities in Hemodialysis Patients: Is Supplementation Necessary?;Frontiers in Nutrition;2021-09-23

4. Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides;Postgraduate Medicine;2019-07-25

5. Effects of Marine n-3 Polyunsaturated Fatty Acids on Heart Rate Variability and Heart Rate in Patients on Chronic Dialysis: A Randomized Controlled Trial;Nutrients;2018-09-17